Trial Profile

A Phase 3, Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain for Which Parenteral Opioid Therapy is Warranted

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 12 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Oliceridine (Primary)
Indications Pain; Postoperative pain
Focus Adverse reactions; Registrational
Acronyms ATHENA-1
Sponsors Trevena

Most Recent Events

30 May 2023 According to sun Pharma Media release, Data and analysis from 200 patient real-world clinical outcomes study, is expected in mid-2023.
13 Oct 2021 According to a Trevena media release, results from this trial were presented at ANESTHESIOLOGY 2021, the national conference for the American Society of Anesthesiologists (ASA).
13 Oct 2021 Results published in the Trevena media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com